Not available outside of the UK & Ireland.

Application

IONPs may be used in the nanoparticle preparation for evaluation of their antiviral property against H1N1 influenza A virus.

Iron oxide nanoparticles exhibit biocompatibility and non-toxicity and are used as magnetic resonance imaging contrast agents, gene carriers for gene therapy, therapeutic agents for hyperthermia-based cancer treatment, magnetic sensing probes for in vivo diagnostics and for target specific drug delivery.

General description

Recent docking studies highlight the potential interaction of iron oxide (II,III) nanoparticles (IONPs) with the SARS-CoV-2 spike protein receptor binding domain. This may target viral entry in host cells and also render virions inactive.

Legal Information

Product of Ocean Nanotech, LLC.